Dexrazoxane Intravenous and Hydrocodone Extended-Release Tablets
Determining the interaction of Dexrazoxane Intravenous and Hydrocodone Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Dexrazoxane Intravenous-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Dexrazoxane Intravenous-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Dexrazoxane Intravenous-Hydrocortisone
- Dexrazoxane Intravenous-Hydrocortisone (Systemic)
- Dexrazoxane Intravenous-Hydrocortisone 2.5%
- Hydrocodone Extended-Release Tablets-Dextenza Insert
- Hydrocodone Extended-Release Tablets-Dextenza intraocular
- Hydrocodone Extended-Release Tablets-Dextran 40
- Hydrocodone Extended-Release Tablets-Dextran 70 6% in 5% Dextrose high molecular weight
- Hydrocodone Extended-Release Tablets-Dextran 75
- Hydrocodone Extended-Release Tablets-Dextran high molecular weight